Matriptase-2, a serine protease expressed in hepatocytes, is a negative regulator of hepcidin expression. The purpose of the study was to investigate the interaction of matriptase-2 with hemojuvelin protein in vivo. Mice lacking the matriptase-2 proteolytic activity (mask mice) display decreased content of hemojuvelin protein. Vice versa, the absence of hemojuvelin results in decreased liver content of matriptase-2, indicating that the two proteins interact. To further characterize the role of matriptase-2, we investigated iron metabolism in mask mice fed experimental diets. Administration of iron-enriched diet increased liver iron stores as well as hepcidin expression. Treatment of iron-overloaded mask mice with erythropoietin increased hemoglobin and hematocrit, indicating that the response to erythropoietin is intact in mask mice. Feeding of an iron-deficient diet to mask mice significantly increased spleen weight as well as the splenic content of erythroferrone and transferrin receptor proteins, indicating stress erythropoiesis. Liver hepcidin expression was decreased; expression of Id1 was not changed. Overall, the results suggest a complex interaction between matriptase-2 and hemojuvelin, and demonstrate that hepcidin can to some extent be regulated even in the absence of matriptase-2 proteolytic activity.

Department of Anesthesiology Intensive Care and Pain Medicine University Hospital Muenster University of Muenster 48149 Muenster Germany

Institute of Biotechnology Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec Czech Academy of Sciences 252 50 Vestec Czech Republic

Institute of Pathophysiology 1st Faculty of Medicine 128 53 Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc21019086

003      

CZ-PrNML

005      

20210830100649.0

007      

ta

008      

210728s2021 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/ijms22052650 $2 doi

035    __

$a (PubMed)33800732

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Krijt, Jan $u Institute of Pathophysiology, First Faculty of Medicine, 128 53 Prague, Czech Republic

245    10

$a Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in Mask Mice / $c J. Krijt, J. Frýdlová, I. Gurieva, P. Přikryl, M. Báječný, AU. Steinbicker, M. Vokurka, J. Truksa

520    9_

$a Matriptase-2, a serine protease expressed in hepatocytes, is a negative regulator of hepcidin expression. The purpose of the study was to investigate the interaction of matriptase-2 with hemojuvelin protein in vivo. Mice lacking the matriptase-2 proteolytic activity (mask mice) display decreased content of hemojuvelin protein. Vice versa, the absence of hemojuvelin results in decreased liver content of matriptase-2, indicating that the two proteins interact. To further characterize the role of matriptase-2, we investigated iron metabolism in mask mice fed experimental diets. Administration of iron-enriched diet increased liver iron stores as well as hepcidin expression. Treatment of iron-overloaded mask mice with erythropoietin increased hemoglobin and hematocrit, indicating that the response to erythropoietin is intact in mask mice. Feeding of an iron-deficient diet to mask mice significantly increased spleen weight as well as the splenic content of erythroferrone and transferrin receptor proteins, indicating stress erythropoiesis. Liver hepcidin expression was decreased; expression of Id1 was not changed. Overall, the results suggest a complex interaction between matriptase-2 and hemojuvelin, and demonstrate that hepcidin can to some extent be regulated even in the absence of matriptase-2 proteolytic activity.

650    _2

$a zvířata $7 D000818

650    _2

$a kostní morfogenetický protein 6 $x biosyntéza $x genetika $7 D055418

650    _2

$a erythropoetin $x farmakologie $7 D004921

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a GPI-vázané proteiny $x biosyntéza $x nedostatek $x genetika $x fyziologie $7 D058851

650    _2

$a regulace genové exprese $x účinky léků $7 D005786

650    _2

$a protein hemochromatózy $x biosyntéza $x nedostatek $x genetika $x fyziologie $7 D000071020

650    _2

$a hepcidiny $x biosyntéza $x genetika $7 D064451

650    _2

$a inhibitor diferenciace 1 $x biosyntéza $x genetika $7 D051798

650    _2

$a železo $x nedostatek $7 D007501

650    _2

$a přetížení železem $x metabolismus $7 D019190

650    _2

$a dietní železo $x farmakologie $7 D019266

650    _2

$a játra $x metabolismus $7 D008099

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a membránové proteiny $x nedostatek $x genetika $x fyziologie $7 D008565

650    _2

$a myši $7 D051379

650    _2

$a myši inbrední C57BL $7 D008810

650    _2

$a myši knockoutované $7 D018345

650    _2

$a orgánová specificita $7 D009928

650    _2

$a promotorové oblasti (genetika) $x genetika $7 D011401

650    _2

$a proteinové domény $7 D000072417

650    _2

$a rekombinantní proteiny $x metabolismus $7 D011994

650    _2

$a serinové endopeptidasy $x nedostatek $x genetika $x fyziologie $7 D012697

650    _2

$a slezina $x metabolismus $7 D013154

655    _2

$a časopisecké články $7 D016428

700    1_

$a Frýdlová, Jana $u Institute of Pathophysiology, First Faculty of Medicine, 128 53 Prague, Czech Republic

700    1_

$a Gurieva, Iuliia $u Institute of Pathophysiology, First Faculty of Medicine, 128 53 Prague, Czech Republic

700    1_

$a Přikryl, Petr $u Institute of Pathophysiology, First Faculty of Medicine, 128 53 Prague, Czech Republic

700    1_

$a Báječný, Martin $u Institute of Pathophysiology, First Faculty of Medicine, 128 53 Prague, Czech Republic

700    1_

$a Steinbicker, Andrea U $u Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, University of Muenster, 48149 Muenster, Germany

700    1_

$a Vokurka, Martin $u Institute of Pathophysiology, First Faculty of Medicine, 128 53 Prague, Czech Republic

700    1_

$a Truksa, Jaroslav $u Institute of Biotechnology, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Czech Academy of Sciences, 252 50 Vestec, Czech Republic

773    0_

$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 5 (2021)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/33800732 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20210728 $b ABA008

991    __

$a 20210830100649 $b ABA008

999    __

$a ok $b bmc $g 1690006 $s 1139532

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2021 $b 22 $c 5 $e 20210306 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142

GRA    __

$a 18-13103S $p Grantová Agentura České Republiky

GRA    __

$a PROGRES Q26 $p Univerzita Karlova v Praze

GRA    __

$a LQ1604 National Sustainability Program II $p Ministry of Education, Youth and Sports of CR

GRA    __

$a CZ.1.05/1.1.00/02.0109 $p Ministry of Education, Youth and Sports of CR

GRA    __

$a RVO 86652036 $p Czech Academy of Sciences

LZP    __

$a Pubmed-20210728